# Nanobiotix S.A. (NBTX)

> 医疗保健 · FR · 以 EUR 报告

Sponda 的基本面指标，已按通胀调整。

[HTML 版本](https://sponda.capital/zh/NBTX/fundamentals)

## 年度数据

| 年份 | 营业收入 (M) | 净利润 (M) | FCF (M) | 债务 (M) | 股东权益 (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | € 30.13M | € -24.35M | € -34.52M | € 95.32M | € -84.48M |
| 2024 | € -7.45M | € -70.59M | € -21.13M | € 50.90M | € -65.70M |
| 2023 | € 38.42M | € -42.13M | € -13.59M | € 50.57M | € -1.84M |
| 2022 | € 5.22M | € -62.29M | € -40.62M | € 53.17M | € -27.05M |
| 2021 | € 3.16M | € -56.05M | € -35.89M | € 46.02M | € 26.79M |
| 2020 | € 2.91M | € -42.05M | € -34.59M | € 48.98M | € 70.47M |
| 2019 | € 3.17M | € -63.55M | € -52.75M | € 44.53M | € -1.91M |
| 2018 | € 4.40M | € -38.38M | € -33.39M | € 20.52M | € 14.24M |
| 2017 | € 4.78M | € -33.57M | € -28.62M | € 4.73M | € 43.92M |
| 2016 | € 7.06M | € -28.48M | € -24.32M | € 5.67M | € 17.40M |
| 2015 | € 5.28M | € -22.37M | € -24.10M | € 4.60M | € 15.61M |
| 2014 | € 3.65M | € -12.60M | € -12.57M | € 2.32M | € 30.32M |
| 2013 | € 2.10M | € -10.72M | € -9.25M | € 1.11M | € 3.18M |
| 2012 | € 98.5K | € -7.08M | € -5.09M | € 1.43M | € 10.70M |
| 2011 | € 1.85M | € -7.12M | € -6.61M | € 822.2K | € 925.5K |

此视图中不可用的列：annualPriceMultiples, dividends。它们需要实时市场数据，仅在 HTML 页面上显示。

## 杠杆与流动性

| 指标 | 数值 |
| --- | --- |
| 总债务 / 股东权益 | -1.13 |
| 总负债 / 股东权益 | -1.80 |
| 流动比率 | 1.09 |

## 其他视图

- [指标](https://sponda.capital/zh/NBTX.md)
- [图表](https://sponda.capital/zh/NBTX/charts.md)
- [对比](https://sponda.capital/zh/NBTX/compare.md)
- [指标定义](https://sponda.capital/zh/screener.md)

数据截至 2026-08-30。